Article Details

Arbutus Biopharma (NASDAQ:ABUS) Cut to Hold at Zacks Investment Research | MarketBeat

Retrieved on: 2022-03-05 03:05:11

Tags for this article:

Click the tags to see associated articles and topics

Arbutus Biopharma (NASDAQ:ABUS) Cut to Hold at Zacks Investment Research | MarketBeat. View article details on hiswai:

Excerpt

According to Zacks, "Arbutus Biopharma Corporation is a biopharmaceutical company which is focused on discovering, developing and commercializing a ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up